Swixx Biopharma acquires Biopas to enter Latin America

2024-07-04T11:30:00
Spain Colombia Mexico Peru

Cuatrecasas advises Swixx Biopharma on acquiring Biopas in Latin America

Swixx Biopharma acquires Biopas to enter Latin America
July 4, 2024
Cuatrecasas has contributed to advising Swixx Biopharma AG, a global commercial platform dedicated to unlocking access to innovative medicines worldwide, on acquiring Pharma Consulting Group S.A. and its subsidiary Laboratorios Biopas S.A. (Biopas), as part of its strategic expansion into Latin America. 

Biopas is a leading pharmaceutical company in Latin America, specializing in the in-licensing, marketing, and sale of pharmaceutical products. With operational headquarters in Bogota (Colombia), Biopas is one of Latin America’s leading independent marketing and distribution companies for international biopharmaceutical firms. Biopas has a presence in 20 countries, including Latin America’s “Top 5” markets of Argentina, Brazil, Chile, Colombia, and Mexico. Following this transaction, the leadership team will remain at the helm of the combined company in Latin America.

Walder Wyss acted as lead legal advisor for Swixx Biopharma AG and was supported by the law firms Cuatrecasas, Arias Fábrega & Fábrega (ARIFA) and Pérez Alati, Grondona, Benites & Arntsen (PAGBAM) in Latin America. 

July 4, 2024